Keeogo™& Clinicians

Keeogo™ can be used on patients with mobility impairment or endurance issues due to medical conditions, such as osteoarthritis of the knee, multiple sclerosis, Parkinson’s disease, stroke, and more. KeeogoTM may improve walking function, independence and quality of life by reducing pain, compensatory movement patterns and fatigue.

Keeogo™ provides additional strength and stability to help complete a movement only when initiated by the user and is contraindicated for patients with complete spinal cord injury.

Keeogo™ helps patients with:

  • Daily activities at home or int he community, with or without supervision
  • Rehabilitation program with or without direct professional supervision

B-Temia Inc. has a team of clinical specialists who will provide in depth training sessions as well as ongoing clinical and technical support, in addition to comprehensive manuals, to ensure the greatest level of success for clinicians using Keeogo™ with their patients.

Why should I work with Keeogo™?

Since 2010, Keeogo™ has been involved in field testing, product evaluations, and clinical trials. Over 125 participants have tested the device in more than 20 studies. These studies demonstrate how the KeeogoTM has the potential to:

  • Increase Walking Capacity
  • Increase Balance and Stability
  • Reduce Compensatory Movements
  • Reduce Pain
  • Improved Kinetics and Kinematics
  • Results applicable to rehabilitation

For a greater, in-depth look at these potential benefits, consult the Keeogo™ Technical Summary document as provided.

Keeogo™ Clinical Benefits

The benefits of Keeogo™ are currently under investiation and have not yet been clinically proven. The intended functional and clinical benefits for individuals with mobility impairments wearing Keego™ on a regular basis include, but are not limited to, the following:

Functional Benefits

  • Ability to remain active, work
  • Improved safety and stability
  • Improved accessibility
  • Possibility to prolong onset of wheelchair use
  • Overall independence and freedom

Clinical Benefits

  • Improved endurance
  • Improved musculoskeletal health
  • Improved circulation
  • Improved balance
  • Improved posture
  • Improved bladder/bowel function
  • Improved bone health
  • Improved mental health

Keeogo™ Clinical Studies

Keeogo™ has been used by multiple volunteers in contorlled and uncontrolled studies with multiple sclerosis, knee & hip osteoarthritis, Parkinson's disease and peripheral artery disease patient populations and the following collaborators:


  • Laurent Bouyer, PhD, Caroline Rahn, PT, François Routhier, PEng, PhD, Bradford McFadyen, PhD, Center for Interdisciplinary Research in Rehabilitation and Social Integration, IRDPQ, Unversité Laval.
  • Emmanuelle Pourcher MD,Msc,FRCP(C) Neurologist-Movement Disorders Specialist , Neuropharmacologist and Neuropsychiatrist.Clinique Sainte Anne Mémoire et Mouvement /,CHU de Québec / and / , Quebec Mental Health University Institute Research Center, Philippe Corbeil, PhD Kinesiology, Faculty of Medicine, Kinesiology Department, Université Laval, Centre de recherche du CHU de Québec.
  • Dr. Paul Poirier MD PhD, FACC, FAHA, FRCPC, Institut Universitaire de Cardiologie et de Pneumologie de Québec.

Multi-Center Pivotal Clinical Trial

B-TEMIA Inc. has initiated a multi-center pivotal clinical trial, aimed at demonstrating the superior clinical benefits and safety for home use of Keeogo™, for patients living with reduced mobility due to medical conditions. Led by Principal Investigator, Dr. Chris A. McGibbon, PhD, from the University of New Brunswick’s, Faculty of Kinesiology and Institute of Biomedical Engineering, the study is expected to generate the required data to support the submission of a 510(k) pre-market notification to the U.S. Food and Drug Administration in 2016, a prerequisite to start commercialization in the United States.

“This is the first international clinical trial involving the Dermoskeleton™ technology that aims at demonstrating the efficacy and safety of Keeogo™ during everyday community and home mobility use, something that has not been possible in the past with other exoskeleton technologies that were developed principally for use in a clinical rehabilitation setting”, stated Dr. Chris A. McGibbon.

As part of the trial, B-TEMIA has partnered with three of the most reputable rehabilitation institutions in North America: the Rehabilitation Institute of Chicago, the Spaulding Rehabilitation Hospital Boston, and the Toronto Rehabilitation Institute–UHN.

To learn more about how you or your patients may be involved in this clinical trial, contact

Take the next step with Keeogo™

We offer private and group demonstrations across British Columbia.